1 study found for:    PANCREATIC GS 6624 MARYLAND
Show Display Options
Download search resultsDownload the search results for:
PANCREATIC GS 6624 MARYLAND (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Simtuzumab;   Drug: Gemcitabine;   Drug: Placebo to match simtuzumab

Indicates status has not been verified in more than two years